Loading...
XNAS
WGS
Market cap2.28bUSD
Jul 25, Last price  
79.83USD
1D
-1.99%
1Q
-28.09%
IPO
-75.32%
Name

GeneDx Holdings Corp

Chart & Performance

D1W1MN
No data to show
P/E
P/S
7.46
EPS
Div Yield, %
Shrs. gr., 5y
29.87%
Rev. gr., 5y
9.26%
Revenues
305m
+50.79%
196,174,000179,322,000212,195,000234,694,000202,566,000305,450,000
Net income
-52m
L-70.25%
-30,991,000-246,436,000-245,390,000-548,980,000-175,767,000-52,286,000
CFO
-28m
L-84.18%
-18,728,000-93,128,000-190,434,000-319,155,000-180,147,000-28,496,000
Earnings
Jul 28, 2025

Profile

CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
IPO date
Sep 04, 2020
Employees
1,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
305,450
50.79%
202,566
-13.69%
234,694
10.60%
Cost of revenue
325,256
394,921
685,889
Unusual Expense (Income)
NOPBT
(19,806)
(192,355)
(451,195)
NOPBT Margin
Operating Taxes
(343)
(926)
(49,052)
Tax Rate
NOPAT
(19,463)
(191,429)
(402,143)
Net income
(52,286)
-70.25%
(175,767)
-67.98%
(548,980)
123.72%
Dividends
Dividend yield
Proceeds from repurchase of equity
46,496
143,002
200,607
BB yield
-2.25%
-213.89%
-225.11%
Debt
Debt current
3,336
4,144
6,121
Long-term debt
125,174
182,211
132,397
Deferred revenue
54,918
Other long-term liabilities
57,432
69,653
24,018
Net debt
(12,675)
55,220
13,685
Cash flow
Cash from operating activities
(28,496)
(180,147)
(319,155)
CAPEX
(5,491)
(5,711)
(14,322)
Cash from investing activities
(30,132)
(43,726)
(141,326)
Cash from financing activities
44,162
186,238
197,315
FCF
(23,892)
(166,523)
(423,709)
Balance
Cash
141,185
130,148
123,933
Long term investments
987
900
Excess cash
125,912
121,007
113,098
Stockholders' equity
(1,351,642)
(1,299,761)
(1,124,383)
Invested Capital
1,718,576
1,717,201
1,474,490
ROIC
ROCE
EV
Common stock shares outstanding
26,891
24,312
10,237
Price
76.86
2,694.91%
2.75
-68.41%
8.71
-94.09%
Market cap
2,066,859
2,991.42%
66,858
-24.98%
89,117
-81.51%
EV
2,054,184
122,078
102,802
EBITDA
2,147
(156,521)
(391,886)
EV/EBITDA
956.77
Interest
3,032
3,207
Interest/NOPBT